The provider's checklist to improve pregnant women coverage by intermittent preventive malaria treatment in Mali: a pilot implementation study
- PMID: 34656113
- PMCID: PMC8520273
- DOI: 10.1186/s12936-021-03940-7
The provider's checklist to improve pregnant women coverage by intermittent preventive malaria treatment in Mali: a pilot implementation study
Abstract
Background: Intermittent preventive treatment of malaria in pregnancy (IPTp) is a comprehensive treatment protocol of anti-malarial drugs administered to pregnant women to prevent malaria, started at the fourth pregnancy month, with at least three doses of sulfadoxine-pyrimethamine (SP), taken as directly observed treatment (DOT) every 30 days at intervals until childbirth, in combination with other preventive measures. This paper introduces feasibility and adoption concepts as implementation research outcomes (IRO), allowing after a defined intervention, to assess the coverage improvement by IPTp for women attending a reference district hospital in Mali. Specifically, the purpose is to evaluate the feasibility of a reminder tool (provider checklist) to enhance pregnant women's adoption of information about IPTp-SP uptake as immediate and sustained women practices.
Methods: The implementation strategy used a reminder checklist about malaria knowledge and the recommended preventive tools. Then, the checklist feasibility was assessed during routine practices with the adoption-level about pregnant women' knowledge. Quantitative data were collected through a questionnaire distributed to a non-probability purposive sampling targeting 200 pregnant women divided into two groups before and after the checklist intervention. In contrast, the qualitative data were based on in-depth face-to-face gynaecologists' interviews.
Results: Both the IROs (feasibility and adoption) were satisfactory. The gynaecologists agreed to the use of this checklist during routine practice with a recommendation to generalize it to other health providers. After a gynaecologist visit, a significant increase of the adoption-level about prior knowledge and preventive tools was noticed. A total of 83% of participants were not knowledgeable about malaria disease before checklist use versus 15% after. Similarly, coverage of women's SP DOT rose from 0 to 59% after introducing the checklist and the IPTp-SP uptake after the visit was highly significant in the second group. The latter reached 95% of pregnant women with 4-8 months' gestational age, that mostly respected all SP future visits as theoretically scheduled.
Conclusions: Generalizing such a checklist reminder will improve women's knowledge about malaria prevention.
Keywords: Checklist; Implementation strategy; Intermittent preventive treatment; Malaria; Mali; Pregnant women; Sulfadoxine–pyrimethamine.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Increasing the uptake of Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP) through seasonal malaria chemoprevention channel delivery: protocol of a multicenter cluster randomized implementation trial in Mali and Burkina Faso.BMC Public Health. 2024 Jan 2;24(1):43. doi: 10.1186/s12889-023-17529-z. BMC Public Health. 2024. PMID: 38166711 Free PMC article.
-
Determinants of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women (IPTp-SP) in Mali, a household survey.Malar J. 2021 May 22;20(1):231. doi: 10.1186/s12936-021-03764-5. Malar J. 2021. PMID: 34022901 Free PMC article.
-
An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.PLoS One. 2021 Oct 7;16(10):e0257666. doi: 10.1371/journal.pone.0257666. eCollection 2021. PLoS One. 2021. PMID: 34618812 Free PMC article.
-
Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.Drug Saf. 2007;30(6):481-501. doi: 10.2165/00002018-200730060-00003. Drug Saf. 2007. PMID: 17536875 Review.
-
Community-based strategies to increase coverage of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in sub-Saharan Africa: a systematic review, meta-analysis, meta-ethnography, and economic assessment.Lancet Glob Health. 2024 Sep;12(9):e1456-e1469. doi: 10.1016/S2214-109X(24)00228-6. Lancet Glob Health. 2024. PMID: 39151981
Cited by
-
Micro-costing from healthcare professional's perspective and acceptability of cutaneous leishmaniasis diagnostic tools in Morocco: A mixed-methods study.PLOS Glob Public Health. 2024 Mar 28;4(3):e0002534. doi: 10.1371/journal.pgph.0002534. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 38547152 Free PMC article.
-
Enhancing the uptake of intermittent preventive treatment for malaria in pregnancy: a scoping review of interventions and gender-informed approaches.Malar J. 2025 Feb 18;24(1):49. doi: 10.1186/s12936-025-05275-z. Malar J. 2025. PMID: 39966899 Free PMC article.
-
Systematic Review of Mixed Studies on Malaria in Pregnancy: Individual, Cultural and Socioeconomic Determinants of Its Treatment and Prevention.Trop Med Infect Dis. 2022 Dec 8;7(12):423. doi: 10.3390/tropicalmed7120423. Trop Med Infect Dis. 2022. PMID: 36548677 Free PMC article. Review.
-
Coverage and determinants of Intermittent Preventive Treatment in pregnancy (IPTp) in Cameroon, Guinea, Mali, and Nigeria.PLoS One. 2024 Nov 1;19(11):e0313087. doi: 10.1371/journal.pone.0313087. eCollection 2024. PLoS One. 2024. PMID: 39485743 Free PMC article.
References
-
- WHO, Global Malaria Programme. World malaria report 2019. Geneva: World Health Organization; 2019. https://www.who.int/publications/i/item/9789241565721. Accessed 26 Dec 2020.
-
- WHO . Lives at risk: malaria in pregnancy. Geneva: World Health Organization; 2013.
-
- Anaemene B. Health and diseases in Africa. Dev Afr. 2018;71:207–226. doi: 10.1007/978-3-319-66242-8_12. - DOI
-
- WHO Intermittent preventive treatment in pregnancy (IPTp). Geneva: World Health Organization; 2018. https://www.who.int/malaria/areas/preventive_therapies/pregnancy/en. Accessed 26 Dec 2020.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical